Pulse Biosciences's three largest insider shareholders as of May 23, 2026 are Robert W Duggan (Director, 47.71Mn shares), Robert W Duggan (Director, 1.08Mn shares), Mahkam Zanganeh (Director, 725.39K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Robert W Duggan | - | 47,709,140 | 0 | 12 Sep, 2025 |
| Darrin Uecker | Chief Technology Officer | 284,406 | 0 | 18 Sep, 2025 |
| Mahkam Zanganeh | - | 725,395 | 0 | 11 Feb, 2025 |
| Mitchell E. Levinson | Chief Strategy Officer | 93,880 | 46,503 | 30 Sep, 2024 |
| Kevin Patrick Danahy | Chief Commercial Officer | 43,298 | 0 | 23 Feb, 2026 |
| Burke Thomas Barrett | President And Ceo | 63,172 | 0 | 20 Dec, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 23 Mar, 2026 | Darrin Uecker | Restricted Stock Units | A | 100,000 | $0.00 | 100,000 | D | A |
| 23 Mar, 2026 | Darrin Uecker | Restricted Stock Units | A | 100,000 | $0.00 | 100,000 | D | A |
| 18 Feb, 2026 | Kevin Patrick Danahy | Common Stock | A | 5,000 | $1.53 | 48,298 | D | M |
| 18 Feb, 2026 | Kevin Patrick Danahy | Common Stock | D | 5,000 | $23.64 | 43,298 | D | S |
| 18 Feb, 2026 | Kevin Patrick Danahy | Stock Option (right to buy) | D | 5,000 | $0.00 | 300,000 | D | M |
| 12 Feb, 2026 | Kevin Patrick Danahy | Common Stock | A | 20,000 | $1.53 | 63,298 | D | M |
| 12 Feb, 2026 | Kevin Patrick Danahy | Common Stock | D | 20,000 | $23.37 | 43,298 | D | S |
| 13 Feb, 2026 | Kevin Patrick Danahy | Common Stock | A | 20,000 | $1.53 | 63,298 | D | M |
| 13 Feb, 2026 | Kevin Patrick Danahy | Common Stock | D | 20,000 | $23.53 | 43,298 | D | S |
| 17 Feb, 2026 | Kevin Patrick Danahy | Common Stock | A | 20,000 | $1.53 | 63,298 | D | M |
| 17 Feb, 2026 | Kevin Patrick Danahy | Common Stock | D | 20,000 | $23.63 | 43,298 | D | S |
| 12 Feb, 2026 | Kevin Patrick Danahy | Stock Option (right to buy) | D | 20,000 | $0.00 | 345,000 | D | M |
| 13 Feb, 2026 | Kevin Patrick Danahy | Stock Option (right to buy) | D | 20,000 | $0.00 | 325,000 | D | M |
| 17 Feb, 2026 | Kevin Patrick Danahy | Stock Option (right to buy) | D | 20,000 | $0.00 | 305,000 | D | M |
| 09 Feb, 2026 | Kevin Patrick Danahy | Common Stock | A | 20,000 | $1.53 | 63,298 | D | M |
| 09 Feb, 2026 | Kevin Patrick Danahy | Common Stock | D | 20,000 | $21.45 | 43,298 | D | S |
| 10 Feb, 2026 | Kevin Patrick Danahy | Common Stock | A | 20,000 | $1.53 | 63,298 | D | M |
| 10 Feb, 2026 | Kevin Patrick Danahy | Common Stock | D | 20,000 | $23.52 | 43,298 | D | S |
| 11 Feb, 2026 | Kevin Patrick Danahy | Common Stock | A | 20,000 | $1.53 | 63,298 | D | M |
| 11 Feb, 2026 | Kevin Patrick Danahy | Common Stock | D | 20,000 | $25.20 | 43,298 | D | S |